IL17A and type 1 diabetes mellitus: Concerning intracellular cytokine expression profiles in T1D DR, the increase in IL-17A+ PBMCs, especially CD11b+IL-17A+ cells and decrease in CD3+IFN-γ+ cells appear to be critical factors.